Mitesco (MITI) Amortization of Deferred Charges (2020 - 2026)

Mitesco (MITI) posted quarterly Amortization of Deferred Charges of $9127.0 for Q1 2026, down 98.39% quarter-over-quarter from $565431.0 in Q1 2022.

Mitesco (MITI) Amortization of Deferred Charges (2020 - 2026) Analysis & Trends

Mitesco (MITI) has reported Amortization of Deferred Charges for 4 consecutive years, with $9127.0 the latest figure, recorded in Q1 2026.

In Q1 2026, Amortization of Deferred Charges changed N/A year-over-year to $9127.0; the TTM figure through Mar 2026 stood at $9127.0 (changed N/A YoY), while the FY2022 annual figure was $565431.0, changed N/A from the prior year.
Amortization of Deferred Charges declined to $9127.0 in Q1 2026 per MITI's latest filing, from $565431.0 in the prior quarter.
Across five years, Amortization of Deferred Charges topped out at $565431.0 in Q1 2022 and bottomed at $9127.0 in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Veeva Systems	39.72 Bn	32.40 Bn	662.02 Mn
2	BrightSpring Health Services	12.19 Bn	11.64 Bn	492.75 Mn
3	Healthequity	8.79 Bn	8.52 Bn	256.31 Mn
4	10x Genomics	7.31 Bn	6.76 Bn	112.50 Mn
5	Hinge Health	7.10 Bn	6.71 Bn	183.95 Mn
6	MiniMed	5.66 Bn	5.36 Bn	480.00 Mn
7	Waystar Holding	4.76 Bn	4.56 Bn	221.99 Mn
8	Doximity	4.46 Bn	3.77 Bn	132.93 Mn
9	Heartflow	3.66 Bn	3.28 Bn	53.19 Mn
10	Mitesco	533,866.19	532,333.19	-

Download Data